The Community Oncology Conference is unique among educational programs offered to the oncology community. It provides a forum for community-based oncologists and allied professionals to address the complex clinical, technological, legislative, and business-related issues affecting their practices today. In this shifting medical landscape, sharing data and experience and strong advocacy are ever more urgent if we are to continue providing high-quality, affordable, and accessible cancer care.

Program Overview

This CME activity is based on audio and slides of presentations as delivered by the faculty at the Second Annual Community Oncology Conference, held at the Hyatt Regency in Washington, DC, February 8–9, 2007.

Both medically and financially, cancer care has become increasingly complex. While there has been an explosion of effective new drugs, they come at a high cost. With a growing pool of patients, more complicated regimens, and cutbacks in Medicare reimbursement, practitioners and administrators are finding it ever more challenging to continue offering quality care while still operating profitably. Because community practices are committed to facing and overcoming these hurdles, there is a clear need for a focused forum that offers practical, topical, and solution-driven information.

Target Audience

• Practice Managers
• Medical Oncologists
• Hematologists/Oncologists
• Radiation Oncologists
• Oncology Pharmacists
• Oncology Nurses

Educational Objectives

After taking part in this conference, participants will be able to:

• Apply the latest strategies for running a thriving practice
• Implement clinical guidelines and quality standards
• Prepare for operational challenges coming down the pike
• Translate new data into clinical practice
• Identify new approaches to optimizing patient care and management of comorbid conditions

Release date: March 28, 2007
Expiration Date: March 27, 2008

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Reed Medical Education. The EOCME is accredited by the ACCME to provide continuing medical education for physicians.

The EOCME designates this continuing medical education activity for 1 AMA PRA Category 1 Credit™ per session for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty Disclosures

As a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.

Unapproved/Off-Label Use Disclosure

The EOCME requires CME faculty to disclose to the participants:

• When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
• Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Faculty may discuss information about pharmaceutical agents that is outside of FDA-approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Special Needs

We encourage participation by all individuals. If you have any special needs, please contact Briget B. Stronge at (203) 840-5548, or bstronge@reedmeded.com for assistance.

Enduring Education Sponsor:    Sponsor: